Human liver alanine aminopeptidase. Inhibition by amino acids.
Human liver alanine aminopeptidase is inhibited by L-amino acids having hydrophobic side chains such as Phe, Tyr, Trp, Met, and Leu. Blocking of the amino group or the carboxyl group greatly reduces the inhibitory capacity of the amino acid. Kinetic studies demonstrate that inhibition of hydrolysis of the substrate L-Ala-beta-naphthylamide is of the noncompetitive type. Inhibition of the substrate L-Leu-L-Leu is of the mixed type. Inhibition of the substrate L-Ala-L-Ala-L-Ala is of the competitive type. These changes in the mechanism of inhibition are thought to be the result of the binding of the amino acid to the third residue binding site on the enzyme. This is the part of the active center to which the third residue from the amino end of a peptide substrate is normally bound. The inhibitor constants of several alanine oligopeptides are shown to decrease with increasing length through L-Ala-L-Ala-L-Ala-L-Ala, demonstrating that alanine aminopeptidase is a multisited enzyme with three and possibly four residue sites per active center. The inhibitor constant for Gly-Gly--Phe suggesting that indeed the third residue site preferentially binds large hydrophobic residues.
D000409:Alanine; D000410:Alanine Transaminase / Q000302:isolation & purification; D000596:Amino Acids / Q000494:pharmacology*; D000626:Aminopeptidases / Q000037:antagonists & inhibitors*; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D006801:Humans; D007700:Kinetics; D007930:Leucine / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008715:Methionine / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014443:Tyrosine / Q000494:pharmacology
D000596:Amino Acids; D014443:Tyrosine; D010649:Phenylalanine; D008715:Methionine; D000410:Alanine Transaminase; D000626:Aminopeptidases; D007930:Leucine; D000409:Alanine